5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation

5-Fluorouracil (5-FU) remains the first-line treatment for colorectal cancer (CRC). Although 5-FU initially de-bulks the tumor mass, recurrence after chemotherapy is the barrier to effective clinical outcomes for CRC patients. Here, we demonstrate that p53 promotes WNT3 transcription, leading to act...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Nat Commun
Главные авторы: Cho, Yong-Hee, Ro, Eun Ji, Yoon, Jeong-Su, Mizutani, Tomohiro, Kang, Dong-Woo, Park, Jong-Chan, Il Kim, Tae, Clevers, Hans, Choi, Kang-Yell
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7578039/
https://ncbi.nlm.nih.gov/pubmed/33087710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-19173-2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы